Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Recruiting
Observational Study
Gynecologic Cancer
Radiotherapy Side Effect
Radiotherapy; Complications
Survivorship
Progression, Disease
Progression, Clinical
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- IRCCS San Raffaele · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* gynecologic cancer patients
* \>18 years old
* treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)
Exclusion Criteria:
* other tumors
* \> 90 years old
Contacts